Johnson & Johnson‘s chief scientific officer, Dr. Paul Stoffels, and Novartis AG’s global head, drug development and chief medical officer, Dr. Vasant Narasimhan, were part of the star speaker line-up at the BioAsia 2017 meeting held recently in the charming city of Hyderabad, India.
In exclusive interviews with Scrip, both executives shared their views on a wide spectrum of topics including the challenging and exciting aspects of the world of pharma R&D, people issues amid the Trump administration’s tough
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?